TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Ribozyme Sweden AB
Closing information (x1000 SEK)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
10
|
30
|
18 |
| Financial expenses |
0
|
18
|
18 |
| Earnings before taxes |
-12
|
-10
|
-20 |
| EBITDA |
0
|
8
|
-2 |
| Total assets |
1,464
|
1,476
|
1,468 |
| Current assets |
70
|
57
|
49 |
| Current liabilities |
910
|
910
|
892 |
| Equity capital |
554
|
566
|
576 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
37.8%
|
38.3%
|
39.2% |
| Turnover per employee |
10
|
30
|
18 |
| Profit as a percentage of turnover |
-120.0%
|
-33.3%
|
-111.1% |
| Return on assets (ROA) |
-0.8%
|
0.5%
|
-0.1% |
| Current ratio |
7.7%
|
6.3%
|
5.5% |
| Return on equity (ROE) |
-2.2%
|
-1.8%
|
-3.5% |
| Change turnover |
-20
|
12
|
18 |
| Change turnover % |
-67%
|
67% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.